Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.